Toxipra Plus Formulation: Each 2 mL[dose) contains: Clostridium perfringens (Type B, C and D) b Toxoid ->10 IU C. perfringens (Type B, C and D) e Toxoid-5IU Clostridium novyi (Type B) e Toxoid->5 IU Clostridium septicum a Toxoid-->5 IU Clostridium chauvoei- 100% protection Clostridium tetani-->5 IU Suspension For Injection (IM/SC)

Country: Filippini

Lingwa: Ingliż

Sors: FDA (Food And Drug Administration)

Ingredjent attiv:

Inactivated Clostridium perfringens B and € , Clostridium novyi a , Clostridium septicum a , Clostridium chauvoei , Clostridium tetani Vaccine (Vet.)

Disponibbli minn:

HIPRA Philippines Inc.; Distributor: HIPRA Philippines Inc.

INN (Isem Internazzjonali):

Inactivated Clostridium perfringens B and € + Clostridium novyi a + Clostridium septicum a + Clostridium chauvoei + Clostridium tetani Vaccine (Vet.)

Dożaġġ:

Formulation: Each 2 mL[dose) contains: Clostridium perfringens (Type B, C and D) b Toxoid ->10 IU C. perfringens (Type B, C and D) e Toxoid-5IU Clostridium novyi (Type B) e Toxoid->5 IU Clostridium septicum a Toxoid-->5 IU Clostridium chauvoei- 100% protection Clostridium tetani-->5 IU

Għamla farmaċewtika:

Suspension For Injection (IM/SC)

Unitajiet fil-pakkett:

HDPE Plastic Bottle x 100 mL (Box of 1’s)

Manifatturat minn:

Laboratorios Hipra, S.A., Spain

Data ta 'l-awtorizzazzjoni:

2022-03-07